Join Our Movement to Restore Your Right to Pain Relief! #EndPainPatientAbuse

Pain Warriors Unite - (202) 792-5600

Pain Warriors Unite

Calling ALL Pain Warriors, It's NOW or NEVER!



The month of April is shaping up to be our biggest month ever! Not only is there good news on the state front in a couple of states, both the CDC and FDA  publicly released documents on April 9, 2019 that will soon be looked at as the ‘turning point in pain management during the opioid crisis’. 

What we do with this information will determine how quickly we feel the positive effects.

Each of the memes below is a link that will open in a new page to a shareable and printable PDF that needs to be in the hands of every physician/clinic owner, medical board, state and federal policy maker, and possibly most important: every media outlet in the USA!

If we wait until the CDC and/or FDA do this for us, it could be another three years of fighting state laws, federal laws, and little support from anyone. 

The first people to reach out to are your Federal Represtative and 2 Senators. As always, we suggest calling them first to ask for the best/current email for the health staffer and ask whoever answers the phone to pass along a message to the health staffer that you are sending recently released documents straight from the CDC & FDA regarding opioid prescribing and the CDC Guidelines. Then send them to the email you just received with a paragraph about how the CDC Guidelines and forced tapering have affected you. 

Finally, wrap up the email asking them to increases congressional investigation/oversight of the CDC Guidelines’ unintended consequences and of the DEA/DOJ reguarding these agencies policing prescribing without acknowllack of medical knowledge  

Who do i call first?

Use the link below to go to our page that will help you find your Federal Elected Officials

Click here

4/9/19 FDA Safety notice on opioid tapers and rapid discontinuation


The FDA has acknowledged the harms from sudden discontinuation of opioid pain medications. They are now requiring a label change to ensure gradual individualized tapers, when necessary.  

Clarification of CDC Guidelines; page 2 for all CPPs


 EXCERPT: “The Guideline is not intended to deny any patients who suffer with chronic pain from opioid therapy as an option for pain management... Clinical decision-making should be based on the relationship between the clinician and patient...”

Resolution 235 from the American medical association


Read AMA Resolution Here

Human Rights Watch Report


Read Report Here

HHS Task Force Meeting & Comment Period


Comment Now